US11317836B2ActiveUtilityA1

Implantable blood glucose measuring apparatus and method

Assignee: ULSAN NAT INST SCIENCE & TECH UNISTPriority: Jan 26, 2017Filed: Sep 20, 2017Granted: May 3, 2022
Est. expiryJan 26, 2037(~10.5 yrs left)· nominal 20-yr term from priority
H02J 2105/46H02J 50/12A61B 5/145H02J 7/02H01Q 9/28A61B 5/1473A61B 5/0031A61B 2560/0219A61B 5/6876A61B 2562/166A61B 5/14532H01Q 9/285H02J 50/10A61B 5/0004H01Q 9/16A61B 5/742A61B 2562/164H02J 7/025
38
PatentIndex Score
0
Cited by
24
References
8
Claims

Abstract

The present invention relates to non-invasive blood glucose measuring apparatus and method. More specifically, the apparatus is inserted into a blood vessel of a human body, and at a point of time when a measurement is desired, wirelessly transmits power so as to be operated, wherein a dipole antenna-form sensor measures a change in a specific parameter depending on a blood glucose level. The apparatus measures the blood glucose in a non-invasive manner, wherein a display unit that is present outside the human body receives the parameter value through wireless communication and displays a corresponding blood glucose level.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A blood glucose measuring apparatus comprising:
 a measurer comprising a dipole antenna, an integrated circuit (IC) chip configured to transmit a waveform of a predetermined frequency to the dipole antenna, a receiving coil, and a flexible printed circuit board, the measurer configured to be implanted in a blood vessel of a human body, to measure a predetermined parameter of the dipole antenna, and to transmit information on the parameter, the parameter being a reflection coefficient of the dipole antenna based on a waveform transmitted in the blood vessel from the IC chip to the dipole antenna; 
 a charger configured to supply power to the measurer based on a wireless power transfer scheme; and 
 a display configured to receive information on the parameter from the measurer, convert the information into a blood glucose level, and display the blood glucose level. 
 
     
     
       2. The blood glucose measuring apparatus of  claim 1 , wherein the measurer is configured to transmit the information on the parameter to the display using a frequency band of 400 megahertz (MHz) to 405 MHz. 
     
     
       3. The blood glucose measuring apparatus of  claim 1 , wherein the dipole antenna has a length of 10 millimeters (mm) to 50 mm. 
     
     
       4. The blood glucose measuring apparatus of  claim 3 , wherein the display is configured to convert the parameter information into an impedance value and the displayed blood glucose level corresponds to the impedance value. 
     
     
       5. A method of measuring blood glucose, the method comprising:
 providing a measurer, the measurer configured to be implanted in a blood vessel of a human body and comprising a dipole antenna, an integrated circuit (IC) chip, a receiving coil, and a flexible printed circuit board; 
 implanting the measurer into a blood vessel of a human body; 
 transmitting to the dipole antenna, by the IC chip, a waveform of a predetermined frequency through the blood vessel; 
 measuring, by the measurer, a predetermined parameter of the dipole antenna, the parameter being a reflection coefficient of the dipole antenna based on the waveform transmitted in the blood vessel; 
 transferring, by the measurer, information on the parameter to a display; 
 supplying, by a charger, power to the measurer based on a wireless power transfer scheme; and 
 displaying, by the display, a blood glucose level by converting the information on the parameter into the blood glucose level. 
 
     
     
       6. The method of  claim 5 , wherein the measurer is configured to transmit the information on the parameter to the display using a frequency band of 400 megahertz (MHz) to 405 MHz. 
     
     
       7. The method of  claim 5 , wherein the dipole antenna has a length of 10 millimeters (mm) to 50 mm. 
     
     
       8. The method of  claim 7 , wherein the display is configured to convert the parameter information into an impedance value and the displayed blood glucose level corresponds to the impedance value.

Join the waitlist — get patent alerts

Track US11317836B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.